Hidetaka Kurai

Acute effect of add‐on therapy with tofogliflozin, a sodium glucose co‐transporter 2 inhibitor, on 24‐hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase‐4 inhibitors

Y. Aso, T. Jojima, T. Tomaru, 2021, International journal of clinical practice.

Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes

Y. Aso, T. Jojima, T. Tomaru, 2022, International journal of cardiology. Heart & vasculature.

Effects of treatment with methimazole on circulating CD4+ and CD8+ T cells positive for programed cell death protein‐1 and on subsets of CD4+ T cells in untreated hyperthyroid patients with Graves' disease

Y. Aso, T. Jojima, T. Tomaru, 2022, Clinical endocrinology.

Acute effect of add‐on therapy with tofogliflozin, a sodium glucose co‐transporter 2 inhibitor, on 24‐hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase‐4 inhibitors

Y. Aso, T. Jojima, T. Iijima, 2021, International journal of clinical practice.